A patent review of FGFR4 selective inhibition in cancer (2007-2018)

.

Source: Expert Opinion on Therapeutic Patents - May 30, 2019 Category: Drugs & Pharmacology Authors: Alvaro Quintanal-Villalonga Irene Ferrer Sonia Molina-Pinelo Luis Paz-Ares Source Type: research